A study out of Brazil suggests that a simple, low-cost supplement could meaningfully improve how well chemotherapy works against breast cancer. Researchers at the Botucatu School of Medicine at São Paulo State University (FMB-UNESP) found that women who took daily vitamin D alongside chemotherapy were 79% more likely to achieve complete tumor disappearance than women who took a placebo.
At a glance
- Vitamin D supplementation: Women took 2,000 IU of vitamin D daily during chemotherapy — a modest, cost-effective dose rather than a high corrective one.
- Complete response rate: 43% of women in the vitamin D group saw their cancer fully disappear, compared to 24% in the placebo group.
- Study population: 80 women aged 45 and older, all receiving chemotherapy before surgery to shrink their tumors, most of whom were vitamin D-deficient at the start.
Why this finding matters
Breast cancer is the most commonly diagnosed cancer in women worldwide. Chemotherapy before surgery — called neoadjuvant chemotherapy — is a standard approach for many patients, and how completely the tumor responds to that treatment is a strong predictor of long-term outcomes.
A therapy that costs a few dollars a month and could raise the complete response rate by that margin is worth taking seriously. The researchers note that vitamin D is widely available, easy to take, and carries a well-established safety profile at this dose.
Most women in the study were deficient in vitamin D before treatment began — a common finding in cancer patients and in the general population. Correcting that deficiency during chemotherapy may have given the immune system more to work with.
How vitamin D may support cancer treatment
Vitamin D is best known for its role in bone health, but its influence on the immune system runs deeper. It helps regulate immune cell activity and has been shown in lab studies to affect how cancer cells grow and die. The UNESP researchers believe restoring adequate vitamin D levels may help the body respond more aggressively to the cancer during treatment.
What makes the UNESP approach notable is the dose. Rather than using the high supplementation levels sometimes used to rapidly correct deficiency, the team used 2,000 IU daily — a level considered safe for long-term use and practical for integration into a standard treatment plan.
Limitations and next steps
The researchers are careful not to overstate the results. The trial included only 80 participants, and the findings have not yet been replicated at scale. Larger, randomized clinical trials are needed before vitamin D can be formally recommended as a routine add-on for breast cancer chemotherapy.
Still, the direction of the finding is clear and the cost of further investigation is low. The research was published in a peer-reviewed oncology context and adds to a growing body of evidence linking nutritional status and cancer treatment outcomes.
Vitamin D deficiency is also not evenly distributed. Populations with darker skin tones, limited sun exposure, and lower incomes face higher deficiency rates — meaning an affordable supplement-based intervention could matter most for communities that already face worse cancer outcomes. That equity angle is one more reason researchers say follow-up work is urgent.
For now, the UNESP team recommends that oncologists consider testing patients’ vitamin D levels at the start of treatment. Supplementation at a modest dose carries little risk and, if this study holds up, may meaningfully shift the odds in a patient’s favor.
Read more
For more on this story, see: OnlyMyHealth
For more from Good News for Humankind, see:
- U.K. cancer death rates fall to their lowest level on record
- Alzheimer’s risk cut in half by drug in landmark prevention trial
- The Good News for Humankind archive on global health
About this article
- 🤖 This article is AI-generated, based on a framework created by Peter Schulte.
- 🌍 It aims to be inspirational but clear-eyed, accurate, and evidence-based, and grounded in care for the Earth, peace and belonging for all, and human evolution.
- 💬 Leave your notes and suggestions in the comments below — I will do my best to review and implement where appropriate.
- ✉️ One verified piece of good news, one insight from Antihero Project, every weekday morning. Subscribe free.
More Good News
-
Ghana declares its first marine protected area to rescue depleted fish stocks
Ghana’s marine protected area — the country’s first ever — marks a historic turning point for a nation gripped by a quiet fisheries crisis. Established near Cape Three Points in the Western Region, the protected zone restricts or bans fishing activity to allow severely depleted fish populations to recover. Ghana’s coastal stocks have fallen by an estimated 80 percent from historic levels, threatening food security and the livelihoods of millions of small-scale fishers. The declaration also carries regional significance, potentially inspiring neighboring Gulf of Guinea nations to establish coordinated protections of their own.
-
U.S. researchers cut Alzheimer’s risk by half in first-ever prevention trial
Alzheimer’s prevention may have reached a turning point after a landmark trial showed that removing amyloid plaques before symptoms appear can cut the risk of developing the disease by roughly 50%. Researchers at Washington University School of Medicine studied people with rare genetic mutations that make Alzheimer’s nearly inevitable, finding that early, aggressive treatment can genuinely alter the disease’s course. The results, published in The Lancet Neurology, mark the first time any intervention has shown potential to prevent Alzheimer’s from appearing at all, not merely slow its progression. That distinction matters enormously, since amyloid begins accumulating in the brain two…
-
Marie-Louise Eta becomes first female head coach in men’s top-five European leagues
Female head coach Marie-Louise Eta made history on April 11, 2026, when Union Berlin appointed her as interim head coach — becoming the first woman ever to hold a head coaching position in any of men’s top-five European leagues. The Bundesliga club made the move after dismissing Steffen Baumgart, with five matches remaining and real relegation stakes on the line. Eta, 34, had served as assistant coach since 2023 and was already a familiar, trusted presence within the squad. This was no ceremonial gesture — she was handed a survival fight, which is precisely what makes the milestone significant.
